Parkinson's Disease Trial, Recruiting NCT06907589 Sponsor: Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06907589
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthy participants:

  • Adults of any sex, between 50 and 80 years old
  • A score of 24 or higher on a standard memory and thinking test (MMSE)
  • Normal sense of smell based on a specific smell test, with acceptable scores varying by age group (confirm with trial site)
  • No neurological diseases
  • No movement or physical difficulties in the arms, legs, pelvis, or spine caused by injury or other conditions
  • Willing to sign a consent form agreeing to take part in the study

For people with Parkinson's disease:

  • Adults of any sex, between 50 and 80 years old
  • A score of 24 or higher on a standard memory and thinking test (MMSE)
  • Diagnosed with Parkinson's disease, either with no movement complications, or with only mild fluctuations in symptoms during the day — and assessed during a period when symptoms are well-controlled and no involuntary movements are present
  • Parkinson's disease at a mild to moderate stage (Hoehn and Yahr stage 1, 2, or 3) (confirm with trial site)
  • No movement or physical difficulties in the arms, legs, pelvis, or spine caused by injury or other conditions
  • Willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

For healthy participants:

  • Anyone who does not agree to sign the consent form
  • Anyone whose smell test results indicate a reduced sense of smell, based on age-specific cut-off scores (confirm with trial site)
  • Anyone weighing more than 120 kg (approximately 265 lbs)
  • Anyone who is unable to cooperate sufficiently with the study requirements
  • Anyone with an active cancer diagnosis, or who has had cancer with less than 6 years of clear follow-up
  • Anyone with stiff joints in the arms or legs that would prevent them from doing movements properly
  • Anyone with muscle weakness or paralysis in the arms or legs due to nerve damage
  • Anyone with a nerve condition affecting sensation or movement in multiple parts of the body
  • Anyone with a chronic inflammatory condition affecting the joints of the arms or legs
  • Anyone currently experiencing severe dizziness or balance problems
  • Anyone with a neurodegenerative disease
  • Anyone currently with a fever
  • Anyone with a blood clot in a vein (venous thrombosis)
  • Anyone with heart or blood vessel problems, or other ongoing conditions that could affect their ability to do physical exercises safely
  • Anyone with back or joint pain that could interfere with doing physical exercises
  • Anyone with a history of recurring neck, arm, lower back, or leg nerve pain

For people with Parkinson's disease:

  • Anyone who does not agree to sign the consent form
  • Anyone with Parkinson's disease at an advanced stage (Hoehn and Yahr stage 4 or 5) (confirm with trial site)
  • Anyone who needs a cane, walker, or another person's help in order to walk
  • Anyone weighing more than 120 kg (approximately 265 lbs)
  • Anyone who is unable to cooperate sufficiently with the study requirements
  • Anyone with an active cancer diagnosis, or who has had cancer with less than 6 years of clear follow-up
  • Anyone with stiff joints in the arms or legs that would prevent them from doing movements properly
  • Anyone with muscle weakness or paralysis in the arms or legs due to nerve damage, or a nerve condition affecting sensation or movement
  • Anyone with a chronic inflammatory condition affecting the joints of the arms or legs
  • Anyone currently experiencing severe dizziness or balance problems
  • Anyone with another neurodegenerative disease in addition to Parkinson's disease
  • Anyone currently with a fever
  • Anyone with a blood clot in a vein (venous thrombosis)
  • Anyone with heart or blood vessel problems, or other ongoing conditions that could affect their ability to do physical exercises safely
  • Anyone with back or joint pain that could interfere with doing physical exercises
  • Anyone with a history of recurring neck, arm, or lower back and leg pain

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +390552758663

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Registry
ClinicalTrials.gov
Start date
13 May 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of repetitions; Number of repetitions; Number of repetitions; Number of repetitions; Number of repetitions; Number of repetitions; Number of repetitions; Number of repetitions; Time to Stand Up; Gait Time; Rotation Time; Fundamental frequency of accelerometer signal; Fundamental frequency of accelerometer signal; Fundamental frequency of accelerometer signal; Fundamental frequency of accelerometer signal; Strides Number

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov